July/August 2019

Review
Current State of Myelodysplastic Syndromes: Standard Treatment Practices and Therapeutic Advances
Mark G Faber, DO; Elizabeth A Griffiths, MD; Swapna Thota, MD

J Clin Pathways. 2019;5(6):43-47. doi:10.25270/jcp.2019.08.00088
Received April 29, 2019; accepted June 14, 2019.

Features

Counterpoint
Incorporating Patient Perspectives and Transparency for Patient-Centered Value Assessment
Tom Valuck, MD, JD; Matthew Castner, MHA

J Clin Pathways. 2019;5(6):40-41. doi:10.25270/jcp.2019.08.00087

Review
Current State of Myelodysplastic Syndromes: Standard Treatment Practices and Therapeutic Advances
Mark G Faber, DO; Elizabeth A Griffiths, MD; Swapna Thota, MD

J Clin Pathways. 2019;5(6):43-47. doi:10.25270/jcp.2019.08.00088
Received April 29, 2019; accepted June 14, 2019.

Columns

Pharma Insights
The Evolution of Value Frameworks and What Is Next
Jeremy Schafer, PharmD, MBA; Larry Blandford, PharmD—Column Editor

J Clin Pathways. 2019;5(6):34-35. doi:10.25270/jcp.2019.08.00090

Clinical Pathways GPS
Ramifications of “Medicare for All” and Implications for Clinical Pathways
Matthew Pakizegee, PharmD, MS; Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

J Clin Pathways. 2019;5(6):32-33. doi:10.25270/jcp.2019.08.00089

Patient Perspective
Can We Talk? Discussing What Matters With the People Who Matter
Melissa Williams, MPH; Rebecca Kirch, JD; Alan Balch, PhD—Column Editor

J Clin Pathways. 2019;5(6):24-26. doi:10.25270/jcp.2019.06.00080

Editorial
Strategic Vision of the OCM 2.0 Alternative Payment Model
JCP Editors

J Clin Pathways. 2019;5(6):14-15.

Departments

Interview
Emerging Data Initiatives Using Real-World Evidence to Better Inform Oncology Care
JCP Editors

J Clin Pathways. 2019;5(6):16-19.

Research in Review
Research in Review
JCP Editors

J Clin Pathways. 2019;5(6):9-13.

Editor's Page
Where We Are With Value Assessment in Oncology
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2019;5(6):7.

Back to Top